Principles in Microbiome Engineering. Группа авторов

van Nood, E., Vrieze, A., Nieuwdrop, M., Fuentes, S., et al. (2013). Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368 (5): 407–415.

      278 278 Everard, A., Lazarevic, V., Derrien, M., Girard, M., et al. (2011). Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet‐induced leptin‐resistant mice. Diabetes 60 (11): 2775–2786.

      279 279 Cohen, J.C., Horton, J.D., and Hobbs, H.H. (2011). Human fatty liver disease: old questions and new insights. Science 332 (6037): 1519–1523.

      280 280 Socha, P., Wierzbicka, A., Murawska, J.N., Wlodarek, D., et al. (2007). Nonalcoholic fatty liver disease as a feature of the metabolic syndrome. Rocz. Panstw. Zakl. Hig. 58 (1): 129–137.

      281 281 Compare, D., Coccoli, P., Rocco, A., Nardone, O.M., et al. (2012). Gut–liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 22 (6): 471–476.

      282 282 Abu‐Shanab, A. and Quigley, E.M. (2010). The role of the gut microbiota in nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 7 (12): 691–701.

      283 283 Miura, K. and Ohnishi, H. (2014). Role of gut microbiota and Toll‐like receptors in nonalcoholic fatty liver disease. World J. Gastroenterol. 20 (23): 7381–7391.

      284 284 Delzenne, N.M., Cani, P.D., and Neyrinck, A.M. (2007). Modulation of glucagon‐like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J. Nutr. 137 (11): 2547S–2551S.

      285 285 Barton, W., Penney, N.C., Cronin, O., Garcia‐Perez, I., et al. (2017). The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 67 (4): 625–633.

      286 286 Human Microbiome Project. https://www.hmpdacc.org/ (accessed 14 December 2021).

      287 287 The EC MetaHIT programme. http://www.metahit.eu/ (accessed 14 December 2021).

      288 288 The Microsetta Initiative. https://microsetta.ucsd.edu/ (accessed 14 December 2021).

      289 289 MMHP: Million Microbiomes from Humans Project. https://db.cngb.org/mmhp/ (accessed 14 December 2021).

      290 290 DNBseq™ Technology. https://www.bgi.com/us/dnbseq-ngs-technology/ (accessed 14 December 2021).

      291 291 Data Analysis and Coordination Center (DACC). https://hmpdacc.org/hmp/ (accessed 14 December 2021).

      292 292 Metagenomics of the Elderly programme.http://eldermet.ucc.ie/ https://www.ucc.ie/en/charge‐ucc/eldermet/ (accessed 8 February 2022).

      293 293 Canadian Microbiome Initiative. https://cihr-irsc.gc.ca/e/51498.html (accessed 14 Decmeber 2021).

      294 294 Nishijima, S., Suda, W., Oshima, K., Kim, S., et al. (2016). The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res. 23 (2): 125–133.

      295 295 The Biocodex Microbiota Foundation. https://www.biocodexmicrobiotafoundation.com/foundation (accessed 14 December 2021).

      296 296 The Crohn's & Colitis Foundation.https://site.crohnscolitisfoundation.org/ https://www.crohnscolitisfoundation.org/ (accessed 8 February 2022).

      297 297 The W.GARFIELD WESTON foundation. https://www.westonfoundation.org/our-initiatives/wfmi/ (accessed 14 December 2021).

      298 298 The Wisconsin Alumni Research Foundation (WARF). https://research.wisc.edu/funding/microbiome-initiative/ (accessed 14 December 2021).

Notes

      1 Jiashu Li, Zeyang Qu, and Feng Liu contributed equally.

      2 1 Bill and Melinda Gates foundation.